MARIA SULLIVAN: Open Payments
NPI 1710541040 · BRIDGETON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,617 in 71 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,287 · 2025 $1,617
Food & beverage: $1,517Education: $100
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 23 | $584 |
| Janssen Biotech, Inc. | 6 | $187 |
| ABBVIE INC. | 9 | $177 |
| GENZYME CORPORATION | 3 | $108 |
| Novartis Pharmaceuticals Corporation | 5 | $101 |
| AstraZeneca Pharmaceuticals LP | 6 | $95 |
| PFIZER INC. | 4 | $76 |
| Amgen Inc. | 4 | $68 |
| GlaxoSmithKline, LLC. | 3 | $58 |
| TerSera Therapeutics LLC | 1 | $33 |
Products named: Bimzelx, TREMFYA, RINVOQ, KEVZARA, SAPHNELO, XELJANZ, COSENTYX, BENLYSTA.
Industry payments across MO — which companies pay providers there.
